All News Diagonal Bio AB

Equities

DIABIO

SE0015961826

Delayed Nasdaq Stockholm Other stock markets 06:24:30 2024-04-29 am EDT			5-day change	1st Jan Change
0.073 ^SEK	-2.93%		-20.65%	-79.32%

Apr. 05	Diagonal Bio AB Announces the Extension of Its Partnership with Horsholm Veterinary Clinic	CI
Apr. 05	Diagonal Bio AB Announces Successful Pilot Study Results	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Diagonal Bio AB announces outcome of rights issue	Apr. 24	AQ
Diagonal Bio AB publish - White paper	Apr. 16	AQ
Diagonal Bio AB strengthens its go-to-market strategy through an agreement with founding partner Johan Källstrand	Apr. 10	AQ
The subscription period in Diagonal Bio AB rights issue commences today	Apr. 08	AQ
Diagonal Bio announces successful pilot study results and extended partnership with Hørsholm Veterinary Clinic	Apr. 05	AQ
Diagonal Bio AB Announces the Extension of Its Partnership with Horsholm Veterinary Clinic	Apr. 05	CI
Diagonal Bio AB Announces Successful Pilot Study Results	Apr. 05	CI
Diagonal Bio AB publishes a prospectus because of upcoming rights issue	Apr. 03	AQ
Bulletin from the Extraordinary General Meeting on Tuesday 2[nd] of April in Diagonal Bio AB	Apr. 02	AQ
Diagonal Bio Makes Interim CEO Permanent	Feb. 29	MT
Diagonal Bio appoints Karin Wehlin as new CEO	Feb. 28	AQ
Diagonal Bio Appoints Karin Wehlin as New CEO	Feb. 28	CI
Notice to attend the extraordinary general meeting of Diagonal Bio AB	Feb. 28	AQ
The Board of Directors decides on a preferential rights issue of units in order to finance future development	Feb. 28	AQ
Diagonal Bio AB Year-end Report 2023	Feb. 28	AQ
Diagonal Bio AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 28	CI
Diagonal Bio Signs Product Distribution Deal With Techtum Lab	Feb. 16	MT
Diagonal Bio AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-31	CI
Diagonal Bio AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-22	CI
Diagonal Bio AB announced that it expects to receive SEK 1.8 million in funding	23-08-21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Diagonal Bio AB

Equities

DIABIO

SE0015961826

All News

Filters